Cat. No. | Product name | CAS No. |
DCC4726 |
Sid-7977382
Novel Complement Factor C1 Inhibitor |
349114-29-0 |
DCC4727 |
Silagaba132
Silicon-Containing GABA Derivative, Treating Neuropathic Pain without Central-Nervous-System-Related Side Effects |
1607006-78-9 |
DCC4728 |
Silagaba161
Silicon-Containing GABA Derivative, Treating Neuropathic Pain without Central-Nervous-System-Related Side Effects |
1607006-79-0 |
DCC4729 |
Sila-ibuprofen
Novel COX-I and COX-II inhibitor with four times higher solubility in physiological media and a lower melting enthalpy than ibuprofen |
|
DCC4730 |
Simfibrate
Peroxisome proliferator |
14929-11-4 |
DCC4731 |
Sinapine Sulfate
Antioxidant and antimicrobial agent, counteracting mitochondrial oxidative stress in cardiomyocytes |
6484-83-9 |
DCC4732 |
Sipi-6360
Novel D2/5-HT2A Receptor Dual Antagonist |
1401333-14-9 |
DCC4733 |
Sipi-7623
Novel farnesoid X receptor antagonist |
|
DCC4734 |
Sirt1-a2
Novel SIRT1 Activator |
304448-98-4 |
DCC4735 |
Sirt1-enhancer-a03
First-in-class apolipoprotein E4 (ApoE4)-targeted sirtuin1 (SirT1) enhancer, normalizing sirtuin 1 levels and improving cognition in an Alzheimer's disease mouse model |
60719-82-6 |
DCC4736 |
Sirt1-i5
Novel SIRT1 Inhibitor, showing potent effect on prostate cancer cell line |
601502-36-7 |
DCC4737 |
Sirt1-in-4bb
Novel SIRT1 inhibitor, inducing apoptosis in HCT116 human colon carcinoma cells partially by activating p53 |
|
DCC4738 |
Sirt2-in-6f
Potent and selective inhibitor of SIRT2 |
|
DCC4739 |
Sirt3 Inhibitor P6
Novel selective SIRT3 inhibitor, exhibiting SIRT3 inhibitory selectivity with IC50 value of 7.2 µM over SIRT1 (32.6 µM) and SIRT2 (33.5 µM), showing potent inhibitory activity against a group of MLLr leukemic cell lines |
|
DCC4740 |
Sir-tz
Novel in situ tetrazine ligation reactive silicon-rhodamine dye |
|
DCC4741 |
Sitafloxacin
Potent broad spectrm fluoroquinolone antibiotic |
127254-12-0 |
DCC4742 |
Sitafloxacin Monohydrate
Fluoroquinolone antibiotic, acting as antibacterial, antineoplastic, anti-Infective agents, Inhibiting DNA-gyrase and topoisomerase |
163253-37-0 |
DCC4743 |
Si-w052
Novel inhibitor of lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF)-α and interleukin (IL)-6 on microglia, exhibiting anti-inflammatory activity through ER-stress-mediated autophagy, significantly inducing the conversion ratio of LC3 II/I and |
|
DCC4744 |
Sj1008066
Novel inhibitor of MAGE-A11 with robust activity in TR-FRET for disrupting MAGE-A11:PCF11 interactionm being cell permeable and having improved activity in the TR-FRET assay (IC50 0.13 µM) |
|
DCC4745 |
Sj3366
Unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1), also inhibiting HIV-2 |
195720-26-4 |
DCC4746 |
Sj521054
Novel inhibitor of MAGE-A11 with robust activity in TR-FRET for disrupting MAGE-A11:PCF11 interaction (IC50 0.40 μM) |
|
DCC4747 |
Sj572710
Novel Inhibitor of the Disordered Protein, p27(Kip1) |
328021-97-2 |